(Q39393445)

11 September 2017

title

Systemic rapamycin alone may not be a treatment option for malignant glioma: evidence from an in vivo study (English)

1 reference

11 September 2017

1 reference

3

Piotr Hadaczek

1 reference

11 September 2017

author name string

Marina Mendiburu-Eliçabe

1

1 reference

11 September 2017

Dali Yin

2

1 reference

11 September 2017

Yuying Zhai

4

1 reference

11 September 2017

John Forsayeth

5

1 reference

11 September 2017

Krystof S Bankiewicz

6

1 reference

11 September 2017

publication date

17 February 2012

1 reference

Journal of Neuro-Oncology

11 September 2017

published in

1 reference

11 September 2017

volume

108

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

53-58

1 reference

Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

Glioblastoma multiforme: the terminator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

The role of chemotherapy in recurrent malignant gliomas: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

PI 3-kinase, mTOR, protein synthesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

Mechanisms of action of rapamycin in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0804-9

The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery

21 January 2018

1 reference

12 December 2020

Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells

1 reference

12 December 2020

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

1 reference

12 December 2020

1 reference

12 December 2020

A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells

1 reference

12 December 2020

Dose-dependent pharmacokinetics of rapamycin-28-N,N-dimethylglycinate in the mouse

1 reference

12 December 2020

Pten signaling in gliomas

1 reference

12 December 2020

10.1007/S11060-012-0804-9

Identifiers

DOI

1 reference

release_weyxhrgrv5e7tirn6miy33u6ou

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/weyxhrgrv5e7tirn6miy33u6ou

24 November 2022

mapped directly with Wikidata item

1 reference